Indoco gets EIR for its production facility in Goa (Plant I) by admin- Wednesday, May 3rd, 2023 06:12:24 PM
Indoco Remedies obtained an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) fame from the US Food and Drug Administration (USFDA) for his or her facility for solid dosages (Plant I) positioned in Verna, Goa.
The latest inspection held from January sixteen, 2023, to January 20, 2023, become a surveillance inspection.
The receipt of the EIR with VAI repute additionally signifies the approaching closeout of the Warning Letter issued by the USFDA in July 2019 for the producing site, located at L-14, Verna Industrial Road, Goa (Plant I).
Indoco expects this transformation in compliance popularity to pave the way for approvals of ANDAs submitted from this web site.